Laddar...
Bedaquiline and delamanid in the treatment of multidrug‐resistant tuberculosis: Promising but challenging
Improving treatment outcomes in multidrug‐resistant tuberculosis (MDR‐TB) is partly hampered by inadequate effective antitubercular agents. Development of bedaquiline and delamanid has potentially changed the treatment landscape for MDR‐TB. This review provides an update on the progress of these nov...
Sparad:
| I publikationen: | Drug Dev Res |
|---|---|
| Huvudupphovsmän: | , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
John Wiley & Sons, Inc.
2018
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6590425/ https://ncbi.nlm.nih.gov/pubmed/30548290 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ddr.21498 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|